A Randomized Clinical Trial to Study Ketogenesis and Glucose-Dependent Insulin Secretion Methodologies in Healthy Male Subjects.
Phase of Trial: Phase I
Latest Information Update: 28 Jul 2014
At a glance
- Drugs Oxyntomodulin (Primary)
- Indications Obesity
- Focus Pharmacodynamics
- Sponsors Merck & Co
- 10 Jun 2010 Actual end date (Jun 2010) added as reported by ClinicalTrials.gov.
- 10 Jun 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 27 May 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.